Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tuksin Jearanaiwitayakul, Panya Sunintaboon, Runglawan Chawengkittikul, Jitra Limthongkul, Panuwat Midoeng, Preamrudee Chaisuwirat, Saradee warit & Sukathida Ubol. (2021) Whole inactivated dengue virus-loaded trimethyl chitosan nanoparticle-based vaccine: immunogenic properties in ex vivo and in vivo models. Human Vaccines & Immunotherapeutics 17:8, pages 2793-2807.
Read now
Read now
Articles from other publishers (28)
Tanzeel Zohra, Faryal Saeed, Aamer Ikram, Tariq Khan, Siyab Alam, Muhammad Adil, Ayesha Gul, Saud Almawash & Muhammad Ayaz. (2023) Nanomedicine as a potential novel therapeutic approach against the dengue virus. Nanomedicine 18:22, pages 1567-1584.
Crossref
Crossref
Mst. Sharmin Sultana Shimu, Shafi Mahmud, Trina Ekwati Tallei, Saad Ahmed Sami, Ahmad Akroman Adam, Uzzal Kumar Acharjee, Gobindo Kumar Paul, Talha Bin Emran, Shahriar Zaman, Md. Salah Uddin, Md. Abu Saleh, Sultan Alshehri, Mohammed M Ghoneim, Maha Alruwali, Ahmad J. Obaidullah, Nabilah Rahman Jui, Junghwan Kim & Bonglee Kim. (2022) Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study. Molecules 27:3, pages 653.
Crossref
Crossref
Connor A. P. Scott, Alberto A. Amarilla, Summa Bibby, Natalee D. Newton, Roy A. Hall, Jody Hobson-Peters, David A. Muller, Keith J. Chappell, Paul R. Young, Naphak Modhiran & Daniel Watterson. (2021) Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in Mice. Viruses 13:9, pages 1843.
Crossref
Crossref
Tuksin Jearanaiwitayakul, Panya Sunintaboon, Runglawan Chawengkittikul, Jitra Limthongkul, Panuwat Midoeng, Saradee warit & Sukathida Ubol. (2020) Nanodelivery system enhances the immunogenicity of dengue-2 nonstructural protein 1, DENV-2 NS1. Vaccine 38:43, pages 6814-6825.
Crossref
Crossref
Arianna Mahely Hurtado‐Monzón, Carlos Daniel Cordero‐Rivera, Carlos Noe Farfan‐Morales, Juan Fidel Osuna‐Ramos, Luis Adrián De Jesús‐González, José Manuel Reyes‐Ruiz & Rosa María Ángel. (2020) The role of anti‐flavivirus humoral immune response in protection and pathogenesis. Reviews in Medical Virology 30:4.
Crossref
Crossref
Brahim Benyahia, Larissa Pereira Brumano, Adalberto Pessoa & Francisco Vitor Santos da Silva. 2020. New and Future Developments in Microbial Biotechnology and Bioengineering. New and Future Developments in Microbial Biotechnology and Bioengineering
31
68
.
Doddy Irawan Setyo Utomo, Ichikawa Hirono, Tatsuya Kato & Enoch Y. Park. (2019) Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae. Molecular Biotechnology 61:11, pages 852-859.
Crossref
Crossref
Mansi Verma, Shradha Bhatnagar, Kavita Kumari, Nidhi Mittal, Shivani Sukhralia, Shruthi Gopirajan AT, P.S. Dhanaraj & Rup Lal. (2019) Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets. Gene 695, pages 18-25.
Crossref
Crossref
Mikhail Churakov, Christian J. Villabona-Arenas, Moritz U. G. Kraemer, Henrik Salje & Simon Cauchemez. (2019) Spatio-temporal dynamics of dengue in Brazil: Seasonal travelling waves and determinants of regional synchrony. PLOS Neglected Tropical Diseases 13:4, pages e0007012.
Crossref
Crossref
Eric Mensah & Mohamed E El Zowalaty. (2018) Arboviruses in South Africa, known and unknown. Future Virology 13:11, pages 787-802.
Crossref
Crossref
Paul Ndaya-Oloo, Punnee Pitisuttithum, Nadia G. Tornieporth, Daniel Desgrandchamps, Flor M . Munoz, Sonali Kochhar, Jim Buttery, Jorgen Bauwens & Jan Bonhoeffer. (2018) Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage. The Journal of Clinical Pharmacology 58, pages S123-S139.
Crossref
Crossref
Anwar M. Hashem, Turki Abujamel, Rowa Alhabbab, Mansour Almazroui & Esam I. Azhar. (2018) Dengue infection in patients with febrile illness and its relationship to climate factors: A case study in the city of Jeddah, Saudi Arabia, for the period 2010–2014. Acta Tropica 181, pages 105-111.
Crossref
Crossref
Huiqiang Yang, Huan Yang, Zhushi Li, Lina Liu, Wei Wang, Ting He, Fengming Fan, Yan Sun, Jie Liu, Yuhua Li & Xianwu Zeng. (2018) Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice. Vaccine 36:18, pages 2450-2455.
Crossref
Crossref
Matthew P. Edgington & Luke S. Alphey. (2018) Population dynamics of engineered underdominance and killer-rescue gene drives in the control of disease vectors. PLOS Computational Biology 14:3, pages e1006059.
Crossref
Crossref
Katsuyuki Nakano. (2017) Future risk of dengue fever to workforce and industry through global supply chain. Mitigation and Adaptation Strategies for Global Change 23:3, pages 433-449.
Crossref
Crossref
Roland Züst, Shi-Hua Li, Xuping Xie, Sumathy Velumani, Melissa Chng, Ying-Xiu Toh, Jing Zou, Hongping Dong, Chao Shan, Jassia Pang, Cheng-Feng Qin, Evan W. Newell, Pei-Yong Shi & Katja Fink. (2018) Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants. PLOS ONE 13:1, pages e0189262.
Crossref
Crossref
Hari Pujar & Mats Lundgren. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing
877
898
.
Leah Mathias, Vito Baraka, Anitha Philbert, Ester Innocent, Filbert Francis, Gamba Nkwengulila & Eliningaya J. Kweka. (2017) Habitat productivity and pyrethroid susceptibility status of Aedes aegypti mosquitoes in Dar es Salaam, Tanzania. Infectious Diseases of Poverty 6:1.
Crossref
Crossref
Yalil T. Bracho-Churio, Ruth A. Martínez-Vega, Alfonso J. Rodriguez-Morales, Ronald G. Díaz-Quijano, María L. Luna-González & Fredi A. Diaz-Quijano. (2017) Determinants of felt demand for dengue vaccines in the North Caribbean region of Colombia. Annals of Clinical Microbiology and Antimicrobials 16:1.
Crossref
Crossref
Smith Boonchutima, Kirati Kachentawa, Manasanun Limpavithayakul & Anan Prachansri. (2017) Longitudinal study of Thai people media exposure, knowledge, and behavior on dengue fever prevention and control. Journal of Infection and Public Health 10:6, pages 836-841.
Crossref
Crossref
Matthew P. Edgington & Luke S. Alphey. (2017) Conditions for success of engineered underdominance gene drive systems. Journal of Theoretical Biology 430, pages 128-140.
Crossref
Crossref
D. Aguilera-Pesantes, L.E. Robayo, P.E. Méndez, D. Mollocana, Y. Marrero-Ponce, F.J. Torres & M.A. Méndez. (2017) Discovering key residues of dengue virus NS2b-NS3-protease: New binding sites for antiviral inhibitors design. Biochemical and Biophysical Research Communications 492:4, pages 631-642.
Crossref
Crossref
Narayan Gyawali & Andrew W. Taylor-Robinson. 2017. Dengue - Immunopathology and Control Strategies. Dengue - Immunopathology and Control Strategies.
Luciana C. Vitorino & Layara A. Bessa. (2017) Technological Microbiology: Development and Applications. Frontiers in Microbiology 8.
Crossref
Crossref
Kaifa Wei & Yuhan Li. (2017) Global evolutionary history and spatio-temporal dynamics of dengue virus type 2. Scientific Reports 7:1.
Crossref
Crossref
Hitoshi Tsujimoto, Kathryn A. Hanley, Anitha Sundararajan, Nicholas P. Devitt, Faye D. Schilkey & Immo A. Hansen. (2017) Dengue virus serotype 2 infection alters midgut and carcass gene expression in the Asian tiger mosquito, Aedes albopictus. PLOS ONE 12:2, pages e0171345.
Crossref
Crossref
Michaela U Gack & Michael S Diamond. (2016) Innate immune escape by Dengue and West Nile viruses. Current Opinion in Virology 20, pages 119-128.
Crossref
Crossref
J. A. Swanstrom, J. A. Plante, K. S. Plante, E. F. Young, E. McGowan, E. N. Gallichotte, D. G. Widman, M. T. Heise, A. M. de Silva & R. S. Baric. (2016) Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus. mBio 7:4.
Crossref
Crossref